ION Acquisition Corp 2 Ltd. Completes $253 Million Initial Public Offering

Rhea-AI Summary

ION Acquisition Corp 2 Ltd. has successfully completed its initial public offering, raising $253 million by selling 25,300,000 units at $10.00 each, including 3,300,000 units from an over-allotment option. Each unit consists of one Class A ordinary share and a redeemable warrant. Trading commenced on NYSE under the ticker symbol IACB.U on February 11, 2021. The company aims to pursue business combinations, focusing on innovative Israeli companies. Goldman Sachs and Morgan Stanley managed the offering, with AmeriVet Securities as co-manager.

Positive

• Raised $253 million in gross proceeds from the IPO.
• Focus on rapidly growing Israeli technology and innovation sector.

Negative

• No assurance of successful business combination as per forward-looking statements.

ION Acquisition Corp 2 Ltd. (the “Company”) announced today the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the exercise by the underwriters of their over-allotment option at the initial public offering price. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000.

The Company’s units began trading on the New York Stock Exchange (the “NYSE”) on February 11, 2021 under the ticker symbol “IACB.U.” Each unit consists of one Class A ordinary share and one-eighth of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “IACB” and “IACB WS,” respectively.

The Company is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination target in any business or industry, the Company intends to focus on the rapidly growing universe of Israeli companies and entrepreneurs that apply technology and innovation to everyday lives. The Company is sponsored by ION Holdings 2, LP, an affiliate of ION Asset Management Ltd.

Goldman Sachs & Co. LLC and Morgan Stanley served as joint book-running managers for the offering. AmeriVet Securities acted as co-manager for the offering.

The offering was made only by means of a prospectus. Copies of the prospectus relating to this offering may be obtained from: Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, New York 10282, by telephone: 866-471-2526 or email: prospectus-ny@ny.email.gs.com; or Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, Second Floor, New York, New York 10014.

A registration statement relating to these securities became effective on February 10, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Cautionary Note Concerning Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including statements with respect to the Company’s search for an initial business combination. No assurance can be given that a business combination as discussed above will be completed on the terms described, or at all, or that the proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement for the initial public offering filed with the U.S. Securities and Exchange Commission (the “SEC”). Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210216006162/en/

FAQ

What is the purpose of IACB.U's IPO?

The IPO aims to raise capital for pursuing business combinations, focusing on Israeli technology companies.

When did IACB.U start trading on the NYSE?

ION Acquisition Corp 2 Ltd. began trading on the NYSE on February 11, 2021.

How much did IACB.U raise in its IPO?

ION Acquisition Corp 2 Ltd. raised $253 million through its initial public offering.

What are the components of each unit sold by IACB.U?

Each unit consists of one Class A ordinary share and one-eighth of one redeemable warrant.

What could affect the execution of IACB.U's business combination?

Forward-looking statements indicate there are numerous conditions beyond the company's control that could affect the business combination.